Presentation TVT 2019 Selective Use — Is There a Middle Ground? Presenter: Jeffrey Moses June 13, 2019 REGISTER for free or LOG IN to view this content Structural Heart Presentation TVT 2019 Up Next Presentation TVT 2019 Rationalizing the Cost Effectiveness of Cerebral Protection During TAVR Presenter: Hemal Gada June 13, 2019 More slides + Presentation TVT 2019 OPTIMUM TAV First-In-Human Results Presenter: Mathew Williams June 13, 2019 Presentation TVT 2019 Transcatheter Aortic Valve Replacement With the ACURATE Neo2 Valve System: 1-Year Clinical and Hemodynamic Outcomes Presenter: Helge Möllmann June 13, 2019 We Recommend
Presentation TVT 2019 Rationalizing the Cost Effectiveness of Cerebral Protection During TAVR Presenter: Hemal Gada June 13, 2019
Presentation TVT 2019 Transcatheter Aortic Valve Replacement With the ACURATE Neo2 Valve System: 1-Year Clinical and Hemodynamic Outcomes Presenter: Helge Möllmann June 13, 2019